Nanocarriers for the Delivery of Combination Drugs
Language: English
Published by Elsevier Science, 2021
- Softcover
- New
Seller: moluna, Greven, Germanymoluna
AbeBooks seller since July 9, 2020
Condition: New
£ 220.68
Quantity: Over 20 available
Add to basketItem description from seller
Seller Inventory # 414829310
- Title
- Nanocarriers for the Delivery of Combination Drugs
- Publisher
- Elsevier Science
- Publication year
- 2021
- Condition
- New
- Binding
- Soft cover
- Language
- English
- ISBN 10
- 0128207795
- ISBN 13
- 9780128207796
- Series
- Book 317 of 393: Micro and Nano Technologies
Nanocarriers for the Delivery of Combination Drugs focuses on the role of nanocarriers in the delivery of combination drugs for the management and treatment of various diseases. Nanocarriers belonging to the category of polymeric nanoparticles, dendrimers, lipidic nanocarriers (like nanoemulsions), liposomes, solid lipid nanoparticles, nanostructured lipid carriers are now being used in the drug delivery of combination drugs. This book helps readers assimilate all the information available surrounding the application of various nanocarrier technologies for the delivery of combination drugs of synthetic and natural origin, including small and large molecules.
This is an important reference source for pharmaceutical scientists and biomaterials scientists who are looking to gain an increased understanding on how nanotechnology is improving the efficiency of combination drug delivery.
- Outlines how nanocarriers are used to enhance combination drug delivery systems
- Assesses the major challenges of delivering combination drugs successfully, and explains how nanocarriers can help meet these challenges
- Explores the characteristics of a variety of nanocarrier material types
"Synopsis" may belong to another edition of this title.
About the Author
Prof. Sanjula Baboota passed her Bachelors and Masters in Pharmacy with distinction from the School of Pharmaceutical Education and Research, Jamia Hamdard in 1993 and 1995 respectively. She was a gold medallist in her post graduate programme. She earned her Ph. D. in the year 2002 from Jamia Hamdard. She is presently working as Professor at Department of Pharmaceutics, School of Pharmaceutical Education and Research, Jamia Hamdard. She has a total experience of about 25 years in teaching, research and mentoring. Prof. Sanjula teaches at undergraduate, post graduate and doctoral levels and has also prepared e-content for postgraduate students on subjects like biopharmaceutics and cosmetics. Her research interests include improving oral bioavailability of BCS class II and Class IV drugs using approaches like complexation, polymeric conjugates, lipid based systems like microemulsions, nanoemulsions, solid lipid nanoparticles and nanostructured lipid carriers. She is actively involved in formulating nanoparticulate drug delivery systems for treatment of neurological disorders and cancer. Recently the research group of Prof. Baboota has expanded their research on formulating nanocarriers of combination drugs as combination drug therapy provides additive or synergistic effect, increases the spectrum of treatment, reduces the side effects, helps in overcoming the resistance, improves patient compliance and targets multiple pathways taking part in disease progression. Encapsulation of combination drugs in nanocarriers helps in overcoming the various biopharmaceutical challenges associated with the them thereby creating opportunities for better treatment. Prof Baboota is actively engaged in supervising post graduate and doctoral research work. More than 65 theses at post graduate level and 30 doctoral research work is being guided by her. Her research work has received financial supports from all the leading sponsoring bodies in India. She has published more than 300 papers which includes original research articles, review articles, proceedings and invited book chapters in edited books in the field of drug delivery. The work has also been presented at various national and international conferences. She has written several textbooks and has contributed chapters in books on controlled and novel drug delivery systems. Prof. Baboota research work has received more than 10886 citations and she is having an h-index of 53 and i10 index of 152 as per the June 2021 Google Scholar data. Prof. Baboota has guest edited thematic issues for internationally reputed journals and also serves as regional editor and editorial board member for several international journals. She is a referee for a number of referred journal of repute and also a reviewer for book proposals of reputed international publishers. She serves as an expert for evaluation of national and international projects of different universities and funding bodies. She is also on examination panel of a number of University both in India and abroad for Ph.D theses evaluation. Prof. Baboota has been bestowed with several honours, a few of them worth mentioning include the research award by UGC, Young Pharmacy teacher of the year award by APTI, Dr. P.D.Sethi research paper annual award for her research paper and several other best paper presentation awards. She has also received certificate of recognition for publication in high impact factor journals and citations from Jamia Hamdard. Prof. Baboota featured in the top scientists in 2019 global list across all fields as per the data released by Stanford University and was awarded level 5 certificate in management and leadership by Chartered management Institute (CMI), United Kingdom.
Prof. Javed Ali passed his BPharm and MPharm with distinction from Jamia Hamdard and bagged gold medals in 1994 and 1996, respectively. He earned a PhD in the year 2000. He was a postdoctoral fellow at the Institute of Pharmaceutical Technology, University of Frankfurt, Germany in 2005. He has a total experience of 25 years in teaching and research. Presently, he is working as a professor at the Department of Pharmaceutics, School of Pharmaceutical Education and Research, and is in-charge of IP Management Cell, Jamia Hamdard, New Delhi. Prof. Ali has been bestowed with several honors; a few of them worth mentioning include the Career Award for Young Teachers by All India Council of Technical Education (2003); APTI-Young Pharmacy Teacher of the year (2004) by Association of Pharmacy Teachers of India; the BOYSCAST Fellowship of Department of Science and Technology, Government of India (2005); American Association of Indian Pharmaceutical Scientists (AAiPS)-IPA Distinguished Educator and Researcher Award 2007 at the Association meeting at San Diego, United States; Research Award 2014 by University Grants Commission, New Delhi; and Indian National Science Academy (INSA) Teachers Award 2018 by INSA, New Delhi for his outstanding teaching methodology and research outputs; in addition, several awards for best paper presentations at conferences of Indian Pharmaceutical Congress, Indian Pharmacy Graduate Association, and Controlled Release Society, Indian Chapter. He has also received certificates of recognition for publications in high-impact factor journals from Jamia Hamdard.
Prof. Ali has received research grants from a large number of agencies including FIP (the Netherlands) and industries. He is actively involved in the field of drug delivery, which includes improvement in oral bioavailability of BCS classes II and IV drugs by polymeric conjugates and nanolipid-based systems and nanoparticulate drug delivery systems for brain delivery. He is supervising scientific research at the postgraduation and the doctoral level. He has guided 76 theses of MPharm and 37 theses of PhD. Presently, 12 PhD theses are under his supervision. He is an external expert for PhD theses of a large number of Indian and foreign universities. He has written several books and has contributed several chapters in books on controlled and novel drug delivery systems of reputed Indian and international publishers. A widely traveled person, he has presented his research work in more than 100 conferences held in India and abroad. He has a list of about 350 manuscripts in journals of repute and five Indian patents granted/applied. He has an h-index of 65, i10 index of 242, and more than 17,000 citations to his credit as per Google Scholar bibliometric data in June, 2021. He has been named in the list of top 2% worldwide scientists in the field of pharmacy and pharmacology and also named in the top scientists in 2019 global list across all fields by a publication of Stanford University in 2019. He has also worked as a paper coordinator of UGC ePathshala project of the Ministry of Education, Government of India, for two papers of pharmaceutical sciences. He is a reviewer to a large number of international and national journals of repute and book proposals from various international publishers. He is an expert for projects review for agencies of various countries. He is on the editorial board of many renowned journals.
"About the title" may belong to another edition of this title.
Shipping rates from Germany to U.S.A.
| Item | 26 to 60 business days | 26 to 60 business days |
|---|---|---|
| First item | £ 41.93 | £ 41.93 |
Payment methods
- Bank Wire Transfer
- Check
- Paypal
Store description
Seller's business information
Moluna GmbH
Engberdingdamm 27
Greven, Germany 48268
Terms of sale
About Us
Legal website operator identification:
Moluna GmbH
Represented by the general manager Helge Blischke
Engberdingdamm 27
48268 Greven
Germany
Telephone: 02571/5698933
Telefax: 02571/5698930
E-Mail: abe@moluna.de
VAT No.: DE296281834
listed in the commercial register of the local court Steinfurt
Commercial register number - Part B of the commercial register - 10553
We are a member of the initiative „FairCommerce“ since 24.07.2015.
For more information, see: www.haendlerbund.de/faircommerce.
Right of withdrawal
If you are a consumer you can withdraw from the contract in accordance with the following. Consumer means any natural person who is acting for purposes which are outside his trade, business, craft or profession.
Information regarding the right of withdrawal
Statutory right to withdraw
You have the right to withdraw from this contract within 14 days without giving any reason.
The withdrawal period will expire after 14 days from the day on which you acquire, or a third party other than the carrier and indicated by you acquires, physical possession of the last good or the last lot or piece.
To exercise the right of withdrawal, electronically fill in and submit a clear statement on our website, under "My Purchases" in "My Account". We will communicate to you an acknowledgement of receipt of such a withdrawal on a durable medium (e.g. by e-mail) without delay.
To meet the withdrawal deadline, it is sufficient for you to send your communication concerning your exercise of the right of withdrawal before the withdrawal period has expired.
Effects of withdrawal
If you withdraw from this contract, we will reimburse to you all payments received from you, including the costs of delivery (except for the supplementary costs arising if you chose a type of delivery other than the least expensive type of standard delivery offered by us).
We may make a deduction from the reimbursement for loss in value of any goods supplied, if the loss is the result of unnecessary handling by you.
We will make the reimbursement without undue delay, and not later than 14 days after the day on which we are informed about your decision to withdraw from this contract.
We will make the reimbursement using the same means of payment as you used for the initial transaction, unless you have expressly agreed otherwise; in any event, you will not incur any fees as a result of such reimbursement.
We may withhold reimbursement until we have received the goods back, or you have supplied evidence of having sent back the goods, whichever is the earliest.
You shall send back the goods or hand them over to moluna, Greven, Germany, without undue delay and in any event not later than 14 days from the day on which you communicate your withdrawal from this contract to us. The deadline is met if you send back the goods before the period of 14 days has expired. You will have to bear the direct cost of returning the goods. You are only liable for any diminished value of the goods resulting from the handling other than what is necessary to establish the nature, characteristics and functioning of the goods.
Exceptions to the right of withdrawal
The right of withdrawal does not apply to:
- The delivery of newspapers, journals or magazines with the exception of subscription contracts; and
- The supply of digital content which is not supplied on a tangible medium (e.g. on a CD or DVD) if you accepted when you placed your order that we could start to deliver it, and that you could not withdraw once delivery had started.